Evidence map›Paper›PMID 35091782›Full record

ArticleClinical rheumatology2022

The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.

Ummusen Kaya Akca, Ezgi Deniz Batu, Seher Sener, Zeynep Balik, Muserref Kasap Cuceoglu, Erdal Atalay, Ozge Basaran, Yelda Bilginer, Seza Ozen

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ummusen Kaya AkcaDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.ORCID http://orcid.org/0000-0002-0426-9432
Ezgi Deniz BatuDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Seher SenerDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Zeynep BalikDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Muserref Kasap CuceogluDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Erdal AtalayDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Ozge BasaranDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Yelda BilginerDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Seza OzenDepartment of Pediatrics, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey. sezaozen@gmail.com.ORCID http://orcid.org/0000-0002-2389-7282
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnthesitis-related arthritis (ERA) could be considered the pediatric equivalent of ankylosing spondylitis in adults albeit with certain significant differences. We aim to evaluate the sensitivity and specificity of the International League of Associations for Rheumatology (ILAR), the Assessment of Spondyloarthritis International Society (ASAS), and the preliminary Pediatric Rheumatology International Trials Organization (PRINTO) classification criteria in ERA patients.

methodThe medical records of ERA patients who were followed up between January 2005 and September 2020 have been analyzed. The control group consisted of patients with oligoarticular JIA (n = 146), polyarticular JIA (n = 55), and psoriatic arthritis (n = 20).

resultsThis retrospective study included 108 ERA (73.1% male) and 221 control patients (25.8% male). The median age at diagnosis for ERA and control patients were 12.5 and 4.0 years, respectively (p < 0.001). Arthritis was observed more frequently in the control group at diagnosis and in the follow-up (p < 0.001 for both), while enthesitis, sacroiliac joint tenderness, and inflammatory back pain were more common in the ERA group both at diagnosis and in the follow-up (p < 0.001 for all). In sacroiliac imaging, 70.1% of ERA patients had positive findings suggestive of sacroiliitis at diagnosis and 78% in the follow-up. The sensitivities of ILAR, PRINTO, ASAS criteria for axial SpA, and peripheral SpA at diagnosis were 74.0%, 57.4%, 21.3%, and 85.1%, respectively which increased to 82.4%, 78.7%, 35.1%, and 92.5%, respectively at follow-up. The specificities were 100%, 100%, 99.1%, and 90.9%, respectively at both diagnosis and follow-up.

conclusionThe ASAS criteria for peripheral SpA were the most sensitive while ILAR and the preliminary PRINTO criteria were the most specific criteria for classifying ERA patients. KEY POINTS: The ASAS criteria for peripheral SpA were the most sensitive criteria for classifying ERA patients. The use of ASAS axial SpA criteria may provide early detection of axial involvement.

Indexed as

Arthritis, JuvenileRheumatologySacroiliitisSpondylarthritisAdultChildFemaleHumansMagnetic Resonance ImagingMaleRetrospective StudiesAnkylosing spondylitisClassification criteriaEnthesitis-related arthritis

Identifiers

PMID35091782
OpenAlexW4210742670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.